Development of 3D Multi-Parametric Ultrasound (MPUS) as a Decision Support Tool for Patients

Part of paid clinical trials in Palo Alto, California.

Sponsor
University of California, San Diego
Study ID
NCT05705219
Status
Recruiting

Conditions

  • Liver Cancer, Adult

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • 3D-MPUS — DIAGNOSTIC_TEST
    Participants will receive approximately \< 20 minutes ultrasound scan to locate the lesion followed by acquisition of 3D-MPUS acquisition.

Study Details

This clinical trial studies how well 3-dimensional multi-parametric ultrasound (3D MPUS) imaging works as a decision-support tool for patients with liver tumors undergoing therapy. Continuous and dynamic imaging of patients undergoing therapy is required to monitor early-phase treatment response.

Key Dates

Start date
Dec 4, 2023
Status verified
Jan 2026
Primary completion
Dec 31, 2027
Completion
Dec 31, 2028

Study Design

Enrollment
80 participants (estimated)

Arms

  • Arm: 3-dimensional multi-parametric ultrasound imaging (3D-MPUS)
    Participants will receive sulfur hexafluoride IV and undergo 3D-MPUS imaging over 20 minutes.

Primary Outcome Measure

Diagnostic yield of the 3D-MPUS data acquisition [ Time Frame: Baseline visit ]

Central Contacts

Locations (3)

FacilityCityStateZIPSite coordinators
Stanford University, School of MedicinePalo AltoCalifornia94305
David Marcellus, BS
(650) 723-4547
Aya Kamaya, MD (PRINCIPAL_INVESTIGATOR)
University of California, San DiegoSan DiegoCalifornia92037
Suzanna Lee
+1(858)-534-1475
Ahmed El Kaffas, PhD (PRINCIPAL_INVESTIGATOR)
Thomas Jefferson HospitalPhiladelphiaPennsylvania19107
Andrej Lyshchik, MD, PhD (PRINCIPAL_INVESTIGATOR)
John Eisenbrey, PhD (SUB_INVESTIGATOR)

Find similar trials in Palo Alto, CA

Related Studies